Nuclivision is a Ghent-based MedTech startup, active in the field of nuclear medicine and Artificial Intelligence (AI). Their mission is to make nuclear medicine safer, more cost-effective, and more efficient for both patients and clinicians.
Nuclivision is currently in the product development phase, marketing an innovative medical software device for PET image enhancement. The technology nuclivision is pioneering has the potential to revolutionize the management of positron emission tomography (PET) scans, which are critical in diagnosing, treating, and monitoring cancer, Parkinson’s, and inflammatory diseases. By potentially reducing the amount of time and radioactive tracer dosage needed during PET scan acquisition, their product promises to deliver enhanced efficiencies.